tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CYBN Stock Latest News

Cybin price target lowered to $70 from $73 at Canaccord
The FlyCybin price target lowered to $70 from $73 at Canaccord
23h ago
CYBN
Cybin Inc. Reports on Governance and Compliance
PremiumCompany Announcements
Cybin Inc. Reports on Governance and Compliance
1d ago
CYBN
Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
PremiumThe Fly
Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
6d ago
ATAI
CMND
Cybin’s Strong Position in Psychedelic Neuropsychiatry: Buy Rating Backed by Advancements and Financial Flexibility
PremiumRatings
Cybin’s Strong Position in Psychedelic Neuropsychiatry: Buy Rating Backed by Advancements and Financial Flexibility
6d ago
CYBN
Options Volatility and Implied Earnings Moves Today, July 01, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, July 01, 2025
8d ago
GBX
MSM
Cybin Inc. Advances Mental Health Innovations with Strategic Partnerships and Clinical Progress
PremiumCompany AnnouncementsCybin Inc. Advances Mental Health Innovations with Strategic Partnerships and Clinical Progress
8d ago
CYBN
Cybin offers up to $500M in convertible debentures
Premium
The Fly
Cybin offers up to $500M in convertible debentures
8d ago
CYBN
Cybin Secures $500 Million Financing to Boost Clinical Programs
Premium
Company Announcements
Cybin Secures $500 Million Financing to Boost Clinical Programs
8d ago
CYBN
Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says
PremiumThe Fly
Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says
15d ago
ATAI
CMND
CYBN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CYBN Earnings this Week: How Will it Perform?
16d ago
CYBN
Trump Trade: President said to weigh possible U.S. strike against Iran
PremiumThe Fly
Trump Trade: President said to weigh possible U.S. strike against Iran
21d ago
F
F
Psychedelic advocates hopeful Trump administration will support space, STAT says
PremiumThe Fly
Psychedelic advocates hopeful Trump administration will support space, STAT says
21d ago
ATAI
CMND
Cybin Advances Phase 3 Program Amid Positive Regulatory Signals
PremiumCompany AnnouncementsCybin Advances Phase 3 Program Amid Positive Regulatory Signals
26d ago
CYBN
Psychedelic: Clearmind engages government, political affairs consulting firm
Premium
The Fly
Psychedelic: Clearmind engages government, political affairs consulting firm
27d ago
ATAI
CMND
Cybin CEO to Present at Neuro Perspectives Conference
Premium
Company Announcements
Cybin CEO to Present at Neuro Perspectives Conference
27d ago
CYBN
Cybin CEO to Speak at Psychedelic Science 2025 Conference
PremiumCompany Announcements
Cybin CEO to Speak at Psychedelic Science 2025 Conference
28d ago
CYBN
Cybin initiated with a Buy at Lucid Capital
PremiumThe Fly
Cybin initiated with a Buy at Lucid Capital
1M ago
CYBN
Psychedelic: atai, Beckly Psytech to combine in all-share transaction
PremiumThe Fly
Psychedelic: atai, Beckly Psytech to combine in all-share transaction
1M ago
ATAI
CMND
Cybin Secures U.S. Patent for CYB004 Program in Anxiety Disorder Treatment
PremiumCompany Announcements
Cybin Secures U.S. Patent for CYB004 Program in Anxiety Disorder Treatment
1M ago
CYBN
Cybin announces additional U.S. patent supporting CYB004
PremiumThe FlyCybin announces additional U.S. patent supporting CYB004
1M ago
CYBN
Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat
Premium
Company Announcements
Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat
2M ago
CYBN
Cybin Supports FDA’s Push for Psychedelic Research
Premium
Company Announcements
Cybin Supports FDA’s Push for Psychedelic Research
2M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >